AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2701294_ITM" title="Facts and information about NDA submitted for lamotrigine for depressive episodes in BD. (News Updates).(GlaxoSmithKline submits New Drug Application for Lamictal for the treatment of bipolar I disorder)(Brief Article)">NDA submitted for lamotrigine for depressive episodes in BD. (News Updates).(GlaxoSmithKline submits New Drug Application for Lamictal for the treatment of bipolar I disorder)(Brief Article)</a>
Close
Set up an RSS feed that alerts you when new articles from Brown University Psychopharmacology Update are available.
Frequently asked questions about RSS feeds
NDA submitted for lamotrigine for depressive episodes in BD. (News Updates).(GlaxoSmithKline submits New Drug Application for Lamictal for the treatment of bipolar I disorder)(Brief Article)
GlaxoSmithKline (GSK) has announced that it has submitted a supplemental New Drug Application(sNDA) to the FDA for lamotrigine (Lamictal) for the long-term delay of relapse or recurrence of depressive episodes in bipolar I disorder (BD). If approved, lamotrigine would be the first drug for this indication. "Many effective treatments are available for the acute mania associated with bipolar disorder, …
Related articles from newspapers, magazines, journals, and more
-
- Guidance for industry on changes to an approved new drug application or...
-
News wire article from: Asia Africa Intelligence Wire
November 22, 2004
700+ words
-
- No improvement in ANDA logjam. (U.S. Food and Drug Administration's approval...
-
Magazine article from: Drug & Cosmetic Industry
Fitzroy, John
August 1, 1991
700+ words
-
- Pharmacia & Upjohn et al.: withdrawal of approval of one new drug application...
-
News wire article from: Asia Africa Intelligence Wire
April 14, 2003
700+ words
-
- Ikaria acquires new drug application for Lucassin.
-
News wire article from: Chemical Business Newsbase
March 30, 2010
700+ words
-
- FDA issues complete response letter to Vivus regarding new drug application...
-
News wire article from: Chemical Business Newsbase
October 28, 2010
700+ words
